Ernst-Josef Todt

Title: Ernst-Josef Todt: Innovator in Pharmaceutical Formulations

Introduction

Ernst-Josef Todt is a notable inventor based in Frankfurt am Main, Germany. He has made a significant contribution to the field of pharmaceuticals with his innovative work in the development of stable formulations that enhance the efficacy of medicinal compounds.

Latest Patents

Ernst-Josef Todt holds a patent for "Otamixaban formulations with improved stability." This invention pertains to a pharmaceutical composition that includes methyl (2R.3R)-2-{3-[amino(imino)methyl]benzyl}-3-{[4-(1-oxidopyridin-4-yl)benzoyl]amino}butanoate, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable acidic reacting compound. The patent also encompasses an aqueous solution or dispersion of the composition along with the process for its preparation. The methods outlined in this patent are aimed at treating subjects suffering from conditions that can be improved through the administration of an inhibitor of Factor Xa.

Career Highlights

Ernst-Josef Todt is associated with Sanofi, a leading global pharmaceutical company. His role within Sanofi has enabled him to work on ground-breaking projects that push the boundaries of pharmaceutical science and improve patient outcomes.

Collaborations

Throughout his career, Ernst-Josef Todt has collaborated with other talented professionals, including his coworkers Walter Kamm and Till Bussemer. Their collective expertise in pharmaceutical research has contributed to the success of the innovations developed under Todt's guidance.

Conclusion

Ernst-Josef Todt is a distinguished inventor whose work on Otamixaban formulations has the potential to revolutionize the treatment of patients in need. His dedication to pharmaceutical innovation highlights the importance of research and collaboration in advancing healthcare solutions.